BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2942080)

  • 21. [T-lymphocyte subsets of bronchoalveolar lavage fluid (BALF) in pulmonary sarcoidosis--correlation with clinical stage].
    Hashimoto K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Mar; 24(3):218-29. PubMed ID: 3488462
    [No Abstract]   [Full Text] [Related]  

  • 22. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.
    Rossi GA; Sacco O; Cosulich E; Damiani G; Corte G; Bargellesi A; Ravazzoni C
    Thorax; 1984 Feb; 39(2):143-9. PubMed ID: 6230751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of broncho-alveolar lavage in the diagnosis, activity determination and follow-up of sarcoidosis. Preliminary report].
    Bauer W; Morell A; Simona R; Baumann HR
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1835-7. PubMed ID: 6218609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current aspects of pulmonary granulomatosis].
    Moisescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):193-202. PubMed ID: 3027856
    [No Abstract]   [Full Text] [Related]  

  • 26. Bronchoalveolar T lymphocytes and pulmonary sarcoidosis.
    Hunninghake GW
    Clin Rev Allergy; 1985 May; 3(2):227-34. PubMed ID: 3886118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of alveolar and peripheral CD45RO+ T-lymphocytes in sarcoidosis.
    Perari MG; Forteleoni GM; Rollo M; Perrella A; Collodoro A; Rottoli P; Vagliasindi M
    Sarcoidosis; 1993 Sep; 10(2):163-4. PubMed ID: 8140318
    [No Abstract]   [Full Text] [Related]  

  • 28. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.
    Ceuppens JL; Lacquet LM; Mariën G; Demedts M; van den Eeckhout A; Stevens E
    Am Rev Respir Dis; 1984 Apr; 129(4):563-8. PubMed ID: 6231871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [T- and B-lymphocyte numbers in bronchoalveolar washings from patients with sarcoidosis].
    Averbakh MM; Moroz AM; Kolodiazhnaia NS; Romanov VV
    Klin Med (Mosk); 1986 Dec; 64(12):44-7. PubMed ID: 3494159
    [No Abstract]   [Full Text] [Related]  

  • 30. Localization of the immune response in sarcoidosis.
    Hunninghake GW; Fulmer JD; Young RC; Gadek JE; Crystal RG
    Am Rev Respir Dis; 1979 Jul; 120(1):49-57. PubMed ID: 313729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstitial lung disease. Assessment by bronchoalveolar lavage.
    Martin WJ; Williams DE; Dines DE; Sanderson DR
    Mayo Clin Proc; 1983 Nov; 58(11):751-7. PubMed ID: 6226835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.
    Lawrence EC; Martin RR; Blaese RM; Teague RB; Awe RJ; Wilson RK; Deaton WJ; Bloom K; Greenberg SD; Stevens PM
    N Engl J Med; 1980 May; 302(21):1186-8. PubMed ID: 7366658
    [No Abstract]   [Full Text] [Related]  

  • 33. Sarcoidosis: historical perspective and immunopathogenesis (Part I).
    Zissel G; Müller-Quernheim J
    Respir Med; 1998 Feb; 92(2):126-39. PubMed ID: 9616502
    [No Abstract]   [Full Text] [Related]  

  • 34. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.
    Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on immunology of sarcoidosis. Report from the Baltimore Conference.
    Ossi E; Rossi GA; Semenzato G
    Sarcoidosis; 1985 Mar; 2(1):16-9. PubMed ID: 2882574
    [No Abstract]   [Full Text] [Related]  

  • 36. [Status of systemic and local immunity in patients with sarcoidosis].
    Chernushenko EF; Goncharova SI; Belianovskaia TI
    Klin Med (Mosk); 1986 Dec; 64(12):40-4. PubMed ID: 3494158
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of the activity and control of the course of sarcoidosis using bronchoalveolar lavage].
    Bauer W; Simona R; Morell A; Baumann HR
    Schweiz Med Wochenschr; 1984 Jun; 114(25):920-4. PubMed ID: 6235580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: analysis by monoclonal antibodies and flow cytometry.
    Ginns LC; Goldenheim PD; Burton RC; Colvin RB; Miller LG; Goldstein G; Hurwitz C; Kazemi H
    Clin Immunol Immunopathol; 1982 Oct; 25(1):11-20. PubMed ID: 6983939
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchoalveolar lavage in patients with the acquired immune deficiency syndrome (AIDS).
    Baughman RP; Solinger A; Hurtubise P; Dohn MN; Walzer PD; Rashkin MC; Dortin D
    AIDS Res; 1983-1984; 1(2):91-7. PubMed ID: 6336265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.